FLGT
Fulgent Genetics Inc

5,733
Mkt Cap
$806.85M
Volume
812,895.00
52W High
$27.36
52W Low
$14.57
PE Ratio
-15.80
FLGT Fundamentals
Price
$26.50
Prev Close
$22.31
Open
$24.04
50D MA
$22.68
Beta
0.86
Avg. Volume
200,783.22
EPS (Annual)
-$1.41
P/B
0.72
Rev/Employee
$215,894.90
Loading...
Loading...
News
all
press releases
Fulgent Genetics (NASDAQ:FLGT) Sets New 12-Month High on Earnings Beat
Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week High on Better-Than-Expected Earnings...
MarketBeat·12h ago
News Placeholder
More News
News Placeholder
Fulgent to Participate in Upcoming Conferences
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
Business Wire·1d ago
News Placeholder
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +158.33% and +3.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Fulgent Reports Third Quarter 2025 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
Business Wire·2d ago
News Placeholder
Evolent Health (EVH) Misses Q3 Earnings Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -50.00% and +2.81%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2d ago
News Placeholder
Fulgent Genetics's Earnings Outlook
read more...
Benzinga·3d ago
News Placeholder
Strength Seen in Schrodinger (SDGR): Can Its 13.8% Jump Turn into More Strength?
Schrodinger (SDGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·19d ago
News Placeholder
Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced...
Business Wire·24d ago
News Placeholder
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +130.43% and +7.80%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced...
Business Wire·9mo ago

Latest FLGT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.